Speakers
Sachin Kheterpal, MD, MBA
Professor of Anesthesiology
Associate Dean for Research IT
PI for MIPACT and Co-PI for THRIVE University of Michigan
Jessica Golbus, MD
Clinical Instructor, Cardiovascular Medicine
Co-I for MIPACT
University of Michigan
Nicole Eyrich, MPH
MIPACT Clinical Research Project Manager University of Michigan
Keywords
MIPACT; Patient-reported outcomes; Virtual recruitment; Cohort Identification Toolkit; VALENTINE study; THRIVE study; Wearable data research; Propofol
Key Points
- The MIPACT study combined patient reported outcome data with electronic health record data and data collected from wearable devices.
- The MIPACT study followed over 7,000 participants for 3 years. Both in-person and virtual recruitment had similar success rates. Participant diversity was a priority during recruitment.
- The Cohort Identification Toolkit provides de-identified mean physiologic and activity data for MIPACT study participants.
- The VALENTINE Study was a prospective randomized controlled study using mobile wearable devices to enhance cardiac rehabilitation.
- Older participants in the VALENTINE study were receptive and capable of using wearable technology to assist data collection for the study.
- THRIVE is pragmatic clinical trial studying Propofol anesthesia in 22 states and 2 countries.
Discussion Themes
Economic barriers to participation may be present when using wearable device technology as an inclusion criteria for a study. There are various methods to reduce these barriers, such as providing participants with the wearable device and a minimal data plan.
There may be limits to the types of participant reported outcomes that can be collected remotely. Ideally, participants will decide what data researchers will have access to.
Read more about MIPACT, VALENTINE, and THRIVE study. Read results from MIPACT and VALENTINE.
Tags
#pctGR, @Collaboratory1